Invitrogen s Peter Welch on the RNAi Research Market

Nov 18, 2005

Premium

Peter Welch
Director of research and development, gene regulation
Invitrogen

At A Glance

Name: Peter Welch

Position: Director of research and development, gene regulation, Invitrogen

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb or 360Dx Premium member?
Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Breaking News

The Scan

Mice With Same-Sex Parents Born

Researchers in China have generated mouse pups from same-sex parents, according to Scientific American.

Don't Touch

Two research teams find a role for PIEZO2 in touch sensitivity after injury and inflammation.

Hong Kong's Research Funding Boost

The South China Morning Post reports that Hong Kong plans to add HK$20 billion (US$2.6 billion) to a research endowment.

This Week in Science

In Science this week: open genetic genealogy databases can lead to the identification of individuals who have not sought testing, and more.

Featured White Papers

iPSC & CRISPR/Cas9 Technologies Enable Precise & Controlled Physiologically Relevant Disease Modeling for Basic & Applied Research

Tissue Section Imaging

In Vivo Validation of Optical Probes

Ex Vivo Imaging Quick Start Guide

Nov

05

Featured Webinar

Overcoming Challenges in Solid Tumor Testing with Advanced AI

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Main menu